Toggle navigation
About Us
Overview
Management Team
Press Room
Careers
Contact us
Healthcare Professionals
Overview
Licenses and Certifications
Publications
Billing Information
Investors
Patients
Overview
Breast Cancer
Metastatic Cancer
Glossary
Billing Information
Make a Payment
Products
Order
Physician Portal
Order a Test
Press Room
1
2
3
4
5
6
7
Clinical Cancer Research Publishes Study Demonstrating Clinically Meaningful and Statistically Significant Prognostic Improvement by the Breast Cancer Index
SM
...
Biotheranostics’ Chief Scientific Officer Nominated for Athena Pinnacle Award
Biotheranostics Raises $32 Million in a Private Equity Financing & Announces Spinout From bioMérieux
Studies Demonstrate Broadening Clinical Utility of Biotheranostics’ Breast Cancer Index Molecular Test in the Extended Endocrine Setting
Yale Study Shows Biotheranostics’ Breast Cancer Index Molecular
SM
Test Impacts Extended Endocrine Therapy Decisions in clinical practice
Biotheranostics Announces Collaboration with DeNovo Sciences to Evaluate Its Proprietary Cancer Biomarkers for Use in Liquid Biopsies
Journal of the National Comprehensive Cancer Network Review Article Highlights Role of Biotheranostics’ Breast Cancer Index
SM
in Optimizing Endocrine Therapy
ASCO Conference Data Show Biotheranostics’ Molecular Tests Significantly Impact Management of Metastatic Cancer Patients
Studies Presented at 2015 ASCO Meeting Demonstrate Predictive Power of Biotheranostics’ Breast Cancer Index
SM
Molecular Test in Endocrine Therapy Decisions
Study Underscores Value of Biotheranostics’ Breast Cancer Index
SM
in Informing Decisions about Long-Term Endocrine Therapy & Assessing Risk of Late Recurrence
Lifetime’s “The Balancing Act” Show for Women to Discuss the Breast Cancer Index
SM
Molecular Test
Biotheranostics Appoints Key Executives to Leadership Team
1
2
3
4
5
6
7